The American Society of Clinical Oncology (ASCO) is backing
legislation (H.R. 1097) that would give the Food and Drug Administration (FDA) the authority to regulate tobacco products. The legislation
explicitly states that nicotine should be regulated as a drug, and tobacco
products as drug delivery devices. The legislation also gives the FDA the
authority to regulate tobacco product advertising and promotion. Reps. Greg
Ganske (R-Iowa), John Dingell (D-Mich), and Henry Waxman (D-Calif) are the
"We greatly appreciate the consistent leadership Reps.
Ganske, Dingell, and Waxman provide on behalf of the federal regulation of
tobacco products," said an ASCO statement. "Smoking accounts for at
least 30% of all cancer deaths, is a major cause of heart disease, and is
associated with conditions ranging from colds and gastric ulcers to chronic
bronchitis, emphysema, and cerebrovascular disease."